stella
beta
Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018) — Stella
Recruiting
Back to Lung Adenocarcinoma trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
Chaoqiang Deng, Shanghai, Please Select
View full record on ClinicalTrials.gov